Reactome | Durante, M

Schema > Person > Entries

created	[InstanceEdit:9653015] Rothfels, Karen, 2019-07-09
dbId	9653017
displayName	Durante, M
firstname	Michael
initial	M
publications	[LiteratureReference:9653011] A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours [LiteratureReference:9733158] Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial
schemaClass	Person
surname	Durante

Cite Us!